XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONSOLIDATED BALANCE SHEET - USD ($)
Mar. 31, 2017
Dec. 31, 2016
Current assets:    
Cash and cash equivalents $ 1,675,197 $ 15,306
Accounts receivable, net 989,279 536,817
Inventory, net 792,931 318,912
Prepaid expenses and other current assets 389,075 127,258
Total current assets 3,846,482 998,293
Restricted Cash 209,622 209,570
Property and equipment, net 9,731 11,064
Patents, net 220,000 250,000
Goodwill 3,474,502 3,474,502
Total assets 7,760,337 4,943,429
Current Liabilities:    
Accounts payable and accrued expenses 2,400,668 1,258,252
Debt 177,802 109,682
Derivative liabilities 96,707 5,792,572
Total current liabilities 2,675,177 7,160,506
Commitments and Contingencies (Note 7)
Stockholders' Equity    
Common Stock, $0.001 par value, 300,000,000 shares authorized, 200,317,230 and 119,402,009 shares issued and outstanding at March 31, 2017 and December 31, 2016, respectively 200,317 119,402
Additional paid in capital 40,947,888 33,456,325
Accumulated deficit (36,064,480) (35,794,206)
Total Stockholders' Deficit 5,085,160 (2,217,077)
Total liabilities and Stockholders' Deficit 7,760,337 4,943,429
Series B Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 1,293 1,293
Series C Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock 107 109
Series D Preferred Stock [Member]    
Stockholders' Equity    
Preferred Stock $ 35 $ 0